Staar Surgical Return on Equity (ROE) Growth & History (STAA)

Staar Surgical's return on equity was −21.70% for fiscal 2025.

View full Staar Surgical company overview

Staar Surgical annual return on equity history

Staar Surgical annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20252026-01-02−21.70%−16.54 pp
20242024-12-27−5.16%−11.07 pp
20232023-12-295.91%−7.36 pp
20222022-12-3013.27%+1.28 pp
20212021-12-3111.99%+8.68 pp
20202021-01-013.31%−6.30 pp
20192020-01-039.61%+3.95 pp
20182018-12-285.67%+10.96 pp
20172017-12-29−5.29%+26.31 pp
20162016-12-30−31.61%−14.40 pp
20152016-01-01−17.20%+4.89 pp
20142015-01-02−22.10%−23.23 pp
20132014-01-031.13%+6.89 pp
20122012-12-28−5.76%−10.96 pp
20112011-12-305.20%+4.95 pp
20102010-12-310.24%

Staar Surgical return on equity trends

Over the last five fiscal years, Staar Surgical's return on equity decreased from 3.31% to −21.70%, a change of −25.01 percentage points. The latest reported quarter, Q2 2026, shows 2.25%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Staar Surgical source filings ↗

Community posts

It’s quiet here.

No posts about STAA yet. Start the conversation.

Write the first post